Metabolic switching of estrogen-related receptor alpha in breast cancer aggression

FEBS J. 2023 Mar;290(6):1473-1476. doi: 10.1111/febs.16750. Epub 2023 Feb 28.

Abstract

Orphan nuclear receptor estrogen-related receptor alpha (ERRα) is an important regulator of energy metabolism, whereas its hyperactivation in breast cancer has been shown to regulate cell migration, proliferation, and tumour development. These findings suggest a fine balance in the status of ERRα in regulating metabolic homeostasis or promoting cancer progression. In this issue, Brindisi et al. have shown that ERRα is endogenously activated by cholesterol and caused breast cancer aggressiveness. This study also supports the anti-tumour mechanisms of cholesterol-lowering drugs such as statins.

Keywords: breast cancer; cholesterol; estrogen-related receptor alpha; metabolism; mitochondria; statin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / metabolism
  • Cell Line, Tumor
  • Cell Proliferation
  • Cholesterol
  • ERRalpha Estrogen-Related Receptor
  • Female
  • Humans
  • Receptors, Estrogen / genetics
  • Receptors, Estrogen / metabolism

Substances

  • Receptors, Estrogen
  • Cholesterol